CAS: 1370651-20-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Ensartinib(X-396) REF: 4Z-E-165001CAS: | - - - | To inquire | Wed 22 May 24 | |
Ensartinib-13C2-d6 REF: 4Z-E-165002CAS: | - - - | To inquire | Wed 22 May 24 | |
Ensartinib REF: 3D-VEC65120CAS: 1370651-20-9 | Min. 95% | To inquire | Wed 26 Jun 24 |
Ref: 4Z-E-165001
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 May 2024
Ref: 4Z-E-165002
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 May 2024
Ensartinib
CAS:1370651-20-9
Ensartinib is an investigational drug that is used to treat some types of cancer, such …
Formula:
C26H27Cl2FN6O3
Purity:
Min. 95%
Molecular weight:
561.4 g/mol
Ref: 3D-VEC65120
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 26 Jun 2024